Jay S. Skyler's most recent trade in Applied Therapeutics Inc was a trade of 200,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 9, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Applied Therapeutics Inc | Jay S. Skyler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2025 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| SAB Biotherapeutics Inc | Jay S. Skyler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| SAB Biotherapeutics Inc | Jay S. Skyler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Applied Therapeutics Inc | Jay S. Skyler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 45,000 | 65,000 (0%) | 0% | 0 | Common Stock | |
| Applied Therapeutics Inc | Jay S. Skyler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 20,000 | 20,000 (0%) | 0% | 0 | Common Stock | |
| DexCom | Jay S. Skyler | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 18 May 2023 | 3,876 | 63,348 (0%) | 0% | 0 | Common Stock | |
| DexCom | Jay S. Skyler | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 18 May 2023 | 3,876 | 0 (0%) | 0% | 0 | Common Stock | |
| Applied Therapeutics Inc | Jay S. Skyler | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 20,460 | 20,460 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Jay S. Skyler | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 20,460 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Jay S. Skyler | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 16,500 | 16,500 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Jay S. Skyler | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 16,500 | 16,500 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Jay S. Skyler | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 16,500 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Jay S. Skyler | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 16,500 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Jay S. Skyler | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 10,230 | 10,230 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Jay S. Skyler | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 10,230 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Jay S. Skyler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2022 | 16,500 | 16,500 | - | - | Stock Option (Right to Buy) | |
| DexCom | Jay S. Skyler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2022 | 969 | 969 (0%) | 0% | 0.0 | 1 | Common Stock |
| DexCom | Jay S. Skyler | Director | Other type of transaction at price $ 0.00 per share. | 20 May 2022 | 900 | 0 (0%) | 0% | 0 | Common Stock | |
| DexCom | Jay S. Skyler | Director | Other type of transaction at price $ 0.00 per share. | 20 May 2022 | 900 | 14,868 (0%) | 0% | 0 | Common Stock | |
| DexCom | Jay S. Skyler | Director | Sale of securities on an exchange or to another person at price $ 426.56 per share. | 22 Jun 2021 | 8,334 | 19,370 (0%) | 0% | 426.6 | 3,554,967 | Common Stock |
| DexCom | Jay S. Skyler | Director | Sale of securities on an exchange or to another person at price $ 425.45 per share. | 22 Jun 2021 | 6,264 | 27,704 (0%) | 0% | 425.5 | 2,665,031 | Common Stock |
| DexCom | Jay S. Skyler | Director | Sale of securities on an exchange or to another person at price $ 427.14 per share. | 22 Jun 2021 | 5,402 | 13,968 (0%) | 0% | 427.1 | 2,307,409 | Common Stock |
| Applied Therapeutics Inc | Jay S. Skyler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2021 | 16,500 | 16,500 | - | - | Stock Option (Right to Buy) | |
| DexCom | Jay S. Skyler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2021 | 900 | 900 (0%) | 0% | 0.0 | 1 | Common Stock |
| DexCom | Jay S. Skyler | Director | Other type of transaction at price $ 0.00 per share. | 21 May 2021 | 822 | 33,968 (0%) | 0% | 0 | Common Stock | |
| DexCom | Jay S. Skyler | Director | Other type of transaction at price $ 0.00 per share. | 21 May 2021 | 822 | 0 (0%) | 0% | 0 | Common Stock |